Stem Cells International

Stem Cells as In Vitro Models of Disease


Publishing date
18 May 2012
Status
Published
Submission deadline
18 Nov 2011

Lead Editor

1Centre for Neuroscience and Department of Pharmacology, The University of Melbourne, Grattan Street and Royal Parade, Parkville, VIC, Australia

2Department of Zoology, The University of Melbourne, Grattan Street and Royal Parade, Parkville, VIC, Australia

3Department of Clinical Sciences, Obstetrics and Gynecology, Lund University, BMC-C14, 221 85 Lund, Sweden

4Institute for Integrated Cell-Material Science (iCeMS), Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan


Stem Cells as In Vitro Models of Disease

Description

Over the last thirty years, medical sciences have made tremendous leaps forward in our ability to isolate, derive, and generate stem cells from the body. Stem cells have been identified and isolated from tissues that were previously thought to be nonregenerative, such as from the adult nervous system. Furthermore, we are now able to generate pluripotent stem cells from human somatic cells. The capacity to isolate and generate stem cells from human tissue has created novel opportunities for their use in regenerative medicine. In addition to their potential use in transplantation, it is becoming more apparent that stem cells can also serve as useful in vitro models to investigate pathogenic processes, since stem cells can now be derived from diseased tissue.

In this special issue, we welcome review and original papers of how different types of stem cells are studied within the context of understanding disease cellular mechanisms. Potential topics include, but are not limited to:

  • Derivation and differentiation of pluripotent/multipotent stem cells from human-diseased tissues
  • Multipotent stem cells derived animal models of disease
  • Genetic manipulation of stem cells to generate a diseased state
  • Differentiation and maturation of stem cells to generate disease state in vitro

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 565083
  • - Editorial

Stem Cells as In Vitro Models of Disease

Mirella Dottori | Mary Familari | ... | Kouichi Hasegawa
  • Special Issue
  • - Volume 2012
  • - Article ID 439219
  • - Review Article

Prospective In Vitro Models of Channelopathies and Cardiomyopathies

Nanako Kawaguchi | Emiko Hayama | ... | Toshio Nakanishi
  • Special Issue
  • - Volume 2012
  • - Article ID 407079
  • - Review Article

Extrafollicular Dermal Melanocyte Stem Cells and Melanoma

James D. Hoerter | Patrick Bradley | ... | Brandon Weiswasser
  • Special Issue
  • - Volume 2012
  • - Article ID 980941
  • - Review Article

Stem Cells as In Vitro Model of Parkinson's Disease

Patricia L. Martínez-Morales | Isabel Liste
  • Special Issue
  • - Volume 2012
  • - Article ID 646725
  • - Review Article

Skin-Derived Precursor Cells as an In Vitro Modelling Tool for the Study of Type 1 Neurofibromatosis

Araika Gutiérrez-Rivera | Haizea Iribar | ... | Ander Izeta
  • Special Issue
  • - Volume 2012
  • - Article ID 629230
  • - Review Article

The Potential of iPS Cells in Synucleinopathy Research

Leonhard Linta | Marianne Stockmann | ... | Stefan Liebau
  • Special Issue
  • - Volume 2012
  • - Article ID 346735
  • - Review Article

Endothelial Progenitors as Tools to Study Vascular Disease

Reinhold J. Medina | Christina L. O'Neill | ... | Alan W. Stitt
Stem Cells International
 Journal metrics
Acceptance rate45%
Submission to final decision76 days
Acceptance to publication35 days
CiteScore3.800
Impact Factor3.902
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.